Abner Herrman & Brock LLC bought a new position in shares of Keurig Dr Pepper Inc (NYSE:KDP) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 59,080 shares of the company’s stock, valued at approximately $1,614,000.
A number of other institutional investors and hedge funds have also bought and sold shares of KDP. MRA Associates USA LLC bought a new stake in Keurig Dr Pepper during the 2nd quarter worth approximately $25,000. Pearl River Capital LLC acquired a new position in shares of Keurig Dr Pepper in the 2nd quarter worth approximately $31,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Keurig Dr Pepper in the 2nd quarter worth approximately $42,000. Trustcore Financial Services LLC lifted its position in shares of Keurig Dr Pepper by 270.9% in the 2nd quarter. Trustcore Financial Services LLC now owns 1,836 shares of the company’s stock worth $53,000 after purchasing an additional 1,341 shares during the period. Finally, Catalyst Capital Advisors LLC lifted its position in shares of Keurig Dr Pepper by 91.4% in the 2nd quarter. Catalyst Capital Advisors LLC now owns 1,950 shares of the company’s stock worth $56,000 after purchasing an additional 931 shares during the period. 19.53% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Keurig Dr Pepper stock traded up $0.34 during trading on Friday, reaching $27.98. 1,039,795 shares of the company traded hands, compared to its average volume of 2,540,271. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.33 and a quick ratio of 0.23. Keurig Dr Pepper Inc has a 1-year low of $22.51 and a 1-year high of $31.06. The company has a 50 day moving average price of $27.21 and a 200-day moving average price of $28.14. The firm has a market capitalization of $37.88 billion, a PE ratio of 26.90, a P/E/G ratio of 1.44 and a beta of 0.46.
Keurig Dr Pepper (NYSE:KDP) last released its earnings results on Thursday, August 8th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.01. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. The company had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $2.86 billion. During the same quarter in the previous year, the company earned $1.30 EPS. Keurig Dr Pepper’s quarterly revenue was up 196.3% compared to the same quarter last year. Equities research analysts expect that Keurig Dr Pepper Inc will post 1.22 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, October 4th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, October 3rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.14%. Keurig Dr Pepper’s payout ratio is presently 57.69%.
In other Keurig Dr Pepper news, Director Robert S. Singer acquired 3,000 shares of the stock in a transaction on Tuesday, August 13th. The shares were purchased at an average price of $28.65 per share, for a total transaction of $85,950.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Mary Beth Denooyer acquired 6,000 shares of the stock in a transaction on Tuesday, August 20th. The shares were acquired at an average price of $27.99 per share, for a total transaction of $167,940.00. The disclosure for this purchase can be found here. Insiders have purchased a total of 74,727 shares of company stock worth $1,771,801 in the last quarter. 0.44% of the stock is owned by corporate insiders.
A number of research analysts have recently issued reports on the stock. ValuEngine upgraded shares of Keurig Dr Pepper from a “strong sell” rating to a “sell” rating in a research report on Thursday. BMO Capital Markets upgraded shares of Keurig Dr Pepper from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $27.00 to $34.00 in a research report on Monday, June 17th. Morgan Stanley set a $24.00 price target on shares of Keurig Dr Pepper and gave the stock a “sell” rating in a research report on Friday, August 9th. Credit Suisse Group assumed coverage on shares of Keurig Dr Pepper in a research report on Wednesday, July 17th. They issued a “neutral” rating and a $27.00 price target on the stock. Finally, Bank of America boosted their price target on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. Keurig Dr Pepper presently has a consensus rating of “Hold” and a consensus target price of $30.27.
Keurig Dr Pepper Profile
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Recommended Story: Trading Strategy
Want to see what other hedge funds are holding KDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Keurig Dr Pepper Inc (NYSE:KDP).
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.